Grant: Operating Grant
Centre for Addiction and Mental Health (Toronto)
$471,028.00
Effects of combined alcohol and cannabis on young drivers' simulated driving
EF 2014-15
Résumé
Alcohol and cannabis are the psychoactive substances most often found in seriously and fatally injured drivers. We recently observed that individuals who reported both driving under the influence of alcohol (DUIA) and of cannabis (DUIC) experienced collision risk nearly 4 times that of individuals who reported DUIA or DUIC alone. Residual or 'hangover' effects of either substance on road safety are not well understood but may be substantial. In a recent study, drivers with alcohol hangover but no other evidence of substance use constituted 18% of a group of police-identified suspected impaired drivers. In our ongoing study of cannabis effects on driving, we have seen preliminary evidence of residual effects up to 48 hours following cannabis use. To date, little information on the combined effects of alcohol and cannabis is available, and the residual effect of combined use has not been examined. This study will examine the acute effects of alcohol and cannabis on driving and the residual effects 24 hours later. Fifty subjects aged 19 to 25 will complete 8 experimental sessions (2 sessions/week). Each week subjects will complete one session with alcohol/drug exposure and simulated driving trial and one session 24 hours later with driving trial only. The order of alcohol/drug conditions will be randomly assigned and will include: 1) placebo cannabis/placebo alcohol, 2) placebo cannabis/alcohol, 3) cannabis/placebo alcohol, and 4) cannabis/alcohol. The target blood alcohol content will be 0.08%. A single dose of cannabis will be administered at 12.5% ± 2% THC. Subjects will be social drinkers and regular users of cannabis, but not heavy/problem users, and must be free of health concerns that would contraindicate use of alcohol or cannabis. Effects on mood and cognition will also be assessed. Studies show that cannabis and alcohol are often used together by young drivers. Identifying factors that affect the collision risks of this population is a public health priority.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
323314
Name
Wickens Christine M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Public, Community & Population Health 2
Projecttitle
Effects of combined alcohol and cannabis on young drivers' simulated driving
Programtype2
Operating Grants
Orgnameinp2
Centre for Addiction and Mental Health (Toronto)
Cihramount2
$471,028
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Acute Pharmacologic Effects Of Cannabis; Alcohol Impaired Driving; Cannabis Impaired Driving; Driving Simulation; Residual Effects Of Alcohol; Residual Effects Of Cannabis; Young Drivers
Abstract
Alcohol and cannabis are the psychoactive substances most often found in seriously and fatally injured drivers. We recently observed that individuals who reported both driving under the influence of alcohol (DUIA) and of cannabis (DUIC) experienced collision risk nearly 4 times that of individuals who reported DUIA or DUIC alone. Residual or 'hangover' effects of either substance on road safety are not well understood but may be substantial. In a recent study, drivers with alcohol hangover but no other evidence of substance use constituted 18% of a group of police-identified suspected impaired drivers. In our ongoing study of cannabis effects on driving, we have seen preliminary evidence of residual effects up to 48 hours following cannabis use. To date, little information on the combined effects of alcohol and cannabis is available, and the residual effect of combined use has not been examined. This study will examine the acute effects of alcohol and cannabis on driving and the residual effects 24 hours later. Fifty subjects aged 19 to 25 will complete 8 experimental sessions (2 sessions/week). Each week subjects will complete one session with alcohol/drug exposure and simulated driving trial and one session 24 hours later with driving trial only. The order of alcohol/drug conditions will be randomly assigned and will include: 1) placebo cannabis/placebo alcohol, 2) placebo cannabis/alcohol, 3) cannabis/placebo alcohol, and 4) cannabis/alcohol. The target blood alcohol content will be 0.08%. A single dose of cannabis will be administered at 12.5% ± 2% THC. Subjects will be social drinkers and regular users of cannabis, but not heavy/problem users, and must be free of health concerns that would contraindicate use of alcohol or cannabis. Effects on mood and cognition will also be assessed. Studies show that cannabis and alcohol are often used together by young drivers. Identifying factors that affect the collision risks of this population is a public health priority.
Competitiondate
201503
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wickens, Christine M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $471,028~ $0~